Rituximab For Treatment Of Severe Jo1-Antibody-Associated Antisynthetase Syndrome With Ild: Ro52-Antibody As A Marker For Disease Severity And Response J. Bauhammer,N. Blank,R. Max,H. Lorenz, U. Wagner,C. FiehnINTERNIST（2015）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
